{"transactions":[{"id":780418,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2026-05-13T10:05:13.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":false,"shares":25610,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 25,610 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 25,610 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":0,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":25610},"source":{"system":"sec-edgar","filing":"0001193125-26-220506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000119312526220506/ownership.xml","form_type":"4"}},{"id":780417,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-13T10:05:13.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":25610,"price":1.0846,"value":27776.606,"ownership":{"direct":true},"balance_after":122222,"source":{"system":"sec-edgar","filing":"0001193125-26-220506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000119312526220506/ownership.xml","form_type":"4"}},{"id":939906,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:40:01.000Z","date":"2026-01-10","kind":"grant","planned":false,"acquired":true,"shares":1548300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 1,548,300 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2027, with the remaining three quarters vesting in equal monthly installments through January 10, 2030, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":1548300,"derivative":{"exercise_price":4.75,"expiration_date":"2036-01-10","underlying":"Common Stock","underlying_shares":1548300},"source":{"system":"sec-edgar","filing":"0001193125-26-011823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000119312526011823/ownership.xml","form_type":"4"}},{"id":1054302,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2025-08-27T10:30:04.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":25610,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 25,610 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 25,610 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 25,610 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 25,610 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":25610,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":25610},"source":{"system":"sec-edgar","filing":"0001193125-25-189087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000119312525189087/ownership.xml","form_type":"4"}},{"id":1054301,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-27T10:30:04.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":25610,"price":0.8677,"value":22221.797,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 25,610 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 25,610 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 25,610 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 25,610 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."}],"balance_after":96612,"source":{"system":"sec-edgar","filing":"0001193125-25-189087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000119312525189087/ownership.xml","form_type":"4"}},{"id":1292813,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T22:53:15.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":684600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 684,600 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":684600,"derivative":{"exercise_price":1.18,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":684600},"source":{"system":"sec-edgar","filing":"0000950170-25-009987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017025009987/ownership.xml","form_type":"4"}},{"id":1389075,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-08T10:05:12.000Z","date":"2024-10-07","kind":"purchase","planned":false,"acquired":true,"shares":36500,"price":1.2115,"value":44219.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.195 to $1.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":71002,"source":{"system":"sec-edgar","filing":"0000950170-24-113401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017024113401/ownership.xml","form_type":"4"}},{"id":1468595,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-26T20:15:02.000Z","date":"2024-06-26","kind":"purchase","planned":false,"acquired":true,"shares":14400,"price":3.473,"value":50011.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.413 to $3.499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":34502,"source":{"system":"sec-edgar","filing":"0000950170-24-077878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017024077878/ownership.xml","form_type":"4"}},{"id":1489433,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T10:05:47.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 165,050 shares of the Issuer's common stock and is fully vested."}],"balance_after":162000,"derivative":{"exercise_price":3.57,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":3050},"source":{"system":"sec-edgar","filing":"0000950170-24-069059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017024069059/ownership.xml","form_type":"4"}},{"id":1489432,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-05T10:05:47.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":3050,"price":3.57,"value":10888.5,"ownership":{"direct":true},"balance_after":20102,"source":{"system":"sec-edgar","filing":"0000950170-24-069059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017024069059/ownership.xml","form_type":"4"}},{"id":1678948,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-16T21:29:46.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":330100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 330,100 shares of the Issuer's common stock, one quarter of which will vest on January 12, 2025, with the remaining three quarters vesting in equal monthly installments through January 12, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":330100,"derivative":{"exercise_price":9.41,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":330100},"source":{"system":"sec-edgar","filing":"0000950170-24-004645","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000095017024004645/ownership.xml","form_type":"4"}},{"id":2043478,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-27T23:04:47.000Z","date":"2023-01-25","kind":"grant","acquired":false,"shares":165050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 165,050 shares of the Issuer's common stock, and will vest upon the Issuer's common stock achieving specified share prices during the four years following the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":165050,"derivative":{"exercise_price":3.57,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":165050},"source":{"system":"sec-edgar","filing":"0000899243-23-002880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924323002880/doc4.xml","form_type":"4"}},{"id":2420854,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T21:38:26.000Z","date":"2022-01-28","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 188,375 shares of the Issuer's common stock, one quarter of which vested on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":176597,"derivative":{"exercise_price":4.67,"expiration_date":"2030-08-05","underlying":"Common Stock","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0000899243-22-003671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924322003671/doc4.xml","form_type":"4"}},{"id":2420853,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-31T21:38:26.000Z","date":"2022-01-28","kind":"exercise","acquired":true,"shares":3926,"price":4.67,"value":18334.42,"ownership":{"direct":true},"balance_after":17052,"source":{"system":"sec-edgar","filing":"0000899243-22-003671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924322003671/doc4.xml","form_type":"4"}},{"id":2436484,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T23:39:24.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":178150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 178,150 shares of the Issuer's common stock, and will vest upon the Issuer's common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":178150,"derivative":{"exercise_price":7.43,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":178150},"source":{"system":"sec-edgar","filing":"0000899243-22-001790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924322001790/doc4.xml","form_type":"4"}},{"id":2514276,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-12T11:10:13.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 188,375 shares of the Issuer's common stock, on quarter of which vested on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":180523,"derivative":{"exercise_price":4.67,"expiration_date":"2030-08-05","underlying":"Common Stock","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0000899243-21-044263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321044263/doc4.xml","form_type":"4"}},{"id":2514275,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-12T11:10:13.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":3926,"price":4.67,"value":18334.42,"ownership":{"direct":true},"balance_after":13126,"source":{"system":"sec-edgar","filing":"0000899243-21-044263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321044263/doc4.xml","form_type":"4"}},{"id":2606437,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-11T20:58:08.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 188,375 shares of the Issuer's common stock, one quarter of which vested on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":184449,"derivative":{"exercise_price":4.67,"expiration_date":"2030-08-05","underlying":"Common Stock","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0000899243-21-032548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321032548/doc4.xml","form_type":"4"}},{"id":2606436,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:58:08.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":3926,"price":4.67,"value":18334.42,"ownership":{"direct":true},"balance_after":9200,"source":{"system":"sec-edgar","filing":"0000899243-21-032548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321032548/doc4.xml","form_type":"4"}},{"id":2696557,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-25T22:59:09.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":4330,"price":25.0688,"value":108547.904,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $24.38 to $25.94. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2610750,"source":{"system":"sec-edgar","filing":"0000899243-21-020597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321020597/doc4.xml","form_type":"4"}},{"id":2696556,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-25T22:59:09.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":6215,"price":25.5582,"value":158844.213,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.02 to $27.15. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2615080,"source":{"system":"sec-edgar","filing":"0000899243-21-020597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321020597/doc4.xml","form_type":"4"}},{"id":2702488,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T00:36:23.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":7378,"price":26.1866,"value":193204.7348,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $24.89 to $26.94. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2621295,"source":{"system":"sec-edgar","filing":"0000899243-21-020286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321020286/doc4.xml","form_type":"4"}},{"id":2702487,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T00:36:23.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":7794,"price":24.6297,"value":191963.8818,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $23.835 to $25.29. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2628673,"source":{"system":"sec-edgar","filing":"0000899243-21-020286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321020286/doc4.xml","form_type":"4"}},{"id":2702486,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T00:36:23.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":4998,"price":26.0491,"value":130193.4018,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.085 to $27.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2636467,"source":{"system":"sec-edgar","filing":"0000899243-21-020286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321020286/doc4.xml","form_type":"4"}},{"id":2709905,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-18T01:07:26.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":6139,"price":26.2804,"value":161335.3756,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.59 to $26.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2641465,"source":{"system":"sec-edgar","filing":"0000899243-21-019686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019686/doc4.xml","form_type":"4"}},{"id":2709904,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-18T01:07:26.000Z","date":"2021-05-14","kind":"sale","acquired":false,"shares":11077,"price":26.2487,"value":290756.8499,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.09 to $27.87. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2647604,"source":{"system":"sec-edgar","filing":"0000899243-21-019686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019686/doc4.xml","form_type":"4"}},{"id":2709903,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-18T01:07:26.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":9856,"price":25.9133,"value":255401.4848,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $24.475 to $28.13. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2658681,"source":{"system":"sec-edgar","filing":"0000899243-21-019686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019686/doc4.xml","form_type":"4"}},{"id":2715830,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:35:14.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":14242,"price":27.2881,"value":388637.1202,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $26.335 to $27.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2668537,"source":{"system":"sec-edgar","filing":"0000899243-21-019310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019310/doc4.xml","form_type":"4"}},{"id":2715829,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:35:14.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":14783,"price":28.0282,"value":414340.8806,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $25.76 to $28.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2682779,"source":{"system":"sec-edgar","filing":"0000899243-21-019310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019310/doc4.xml","form_type":"4"}},{"id":2715828,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:35:14.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":8188,"price":26.9845,"value":220949.086,"ownership":{"direct":false,"nature":"By Houghton Capital Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $26.035 to $29.31. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2697562,"source":{"system":"sec-edgar","filing":"0000899243-21-019310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924321019310/doc4.xml","form_type":"4"}},{"id":2930775,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-28T21:15:08.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":27563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,563 shares of the Issuer's common stock, one quarter of which will vest on December 22, 2021, with the remaining three quarters vesting in equal monthly installments through December 22, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":27563,"derivative":{"exercise_price":53.02,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":27563},"source":{"system":"sec-edgar","filing":"0000899243-20-035187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924320035187/doc4.xml","form_type":"4"}},{"id":3006025,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Preferred Stock","published_at":"2020-10-15T21:23:32.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the IPO and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the IPO and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2719},"source":{"system":"sec-edgar","filing":"0000899243-20-028341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924320028341/doc4.xml","form_type":"4"}},{"id":3006024,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2020-10-15T21:23:32.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the IPO and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2555},"source":{"system":"sec-edgar","filing":"0000899243-20-028341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924320028341/doc4.xml","form_type":"4"}},{"id":3006023,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-15T21:23:32.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":2719,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the IPO and had no expiration date."}],"balance_after":5274,"source":{"system":"sec-edgar","filing":"0000899243-20-028341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924320028341/doc4.xml","form_type":"4"}},{"id":3006022,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":47597,"kind":"person","name":"Schreiber Taylor","position":1,"cik":"0001601942","reported_name":"Schreiber Taylor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-15T21:23:32.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":2555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into 6.85 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") and had no expiration date."}],"balance_after":2555,"source":{"system":"sec-edgar","filing":"0000899243-20-028341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601942/000089924320028341/doc4.xml","form_type":"4"}}]}